Individual and environmental factors associated with infection due to cryptococcus neoformans serotype D

Clinical Infectious Diseases

Volumn 23, Issue 1, 1996, Pages 91-96

  Dromer, Françoise ^b   Mathoulin, Simone ^a   Dupont, Bertrand ^c   Letenneur, Luc ^c   Ronin, Olivier ^c  

^a Centre national d'hemovigilance   (France)

^b INSTITUT PASTEUR   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELLULAR IMMUNITY; CORTICOSTEROID THERAPY; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; PRIORITY JOURNAL; SEROTYPING;

EID: 0029809776     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.1.91     Document Type: Article

References (30)

1. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991;13:1163-9.
2. Ellis DH, Pfeiffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990;336:923-5.
3. Kwon-Chung KJ, Bennett JE. Ciyptococcosis. In: Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea & Febiger, 1992:397-446.
4. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984;120:123-30.
5. Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977;105:582-6.
6. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990;28:1642-4.
7. Pfeiffer T, Ellis D. Environmental isolation of Cryptococcus neoformans gattii from California [letter]. J Infect Dis 1991;163:929-30.
8. Bennett JE, Kwon-Chung KJ, Theodore TS. Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia 1978;16:167-74.
9. Wilson DE, Bennett JE, Bailey JW. Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med 1968;127:820-3.
10. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995;21:28-34.
11. Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetcnt hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20:611-6.
12. Dromer F, Mathoulin S, Dupont B, Laporte A, the French Cryptococcosis Study Group. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). Clin Infect Dis 1996;23:82-90.
13. Dromer F, Guého E, Ronin O, Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J Clin Microbiol 1993;31:359-63.
14. Kwon-Chung KJ, Vanna AK, Howard DH. Ecology and epidemiology of Cryptococcus neoformans: a recent study of isolates in the United States. In: Torres-Rodriguez JM, ed. Proceedings of the 10th Congress of the International Society for Human and Animal Mycology. Barcelona: JR Prous, 1988:107-12.
15. Kapend'a K, Komichelo K, Swinne D, Vandepitte J. Meningitis due to Cryplococcus neoformans biovar gattii in a Zairean AIDS patient [letter]. Eur J Clin Microbiol 1987;6:320-1.
16. Bogaerts J, Taelman H, Batungwanayo J, van de Perre P, Swinne D. Two cases of HIV-associated cryptococcosis due to the variety gattii in Rwanda. Trans R Soc Trop Med Hyg 1993;87:63-4.
17. Clancy MN, Fleischman J, Howard DH, Kwon-Chung KJ, Shimizu RY. Isolation of Cryptococcus neoformans gattii from a patient with AIDS in Southern California [letter]. J Infect Dis 1990;161:809.
18. Rozenbaum R, Goncalves AJ, Wanke B, Vieira W. Cryptococcus neoformans var. gattii in a Brazilian AIDS patient. Mycopathologia 1990;112:33-4.
19. St Germain G, Noël G, Kwon-Chung KJ. Disseminated cryptococcosis due to Cryptococcus neoformans variety gattii in a Canadian patient with AIDS [letter]. Eur J Clin Microbiol Infect Dis 1988;7:587-8.
20. Bottone EJ, Salkin IF, Hurd NJ, Wormser GP. Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J Infect Dis 1987;156:242.
21. Shimizu RY, Howard DH, Clancy MN. The variety of Cryptococcus neoformans in patients with AIDS [letter]. J Infect Dis 1986;154:1042.
22. Rinaldi MG, Drutz DJ, Howell A, Sande MA, Wofsy CB, Hadley WK. Serotypes of Cryptococcus neoformans in patients with AIDS [letter]. J Infect Dis 1986;153:642.
23. Currie BP, Freundlich LF, Casadevall A. Restriction fragment length polymorphism analysis of Cryptocaccus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol 1994;32:1188-92.
24. Swinne D. Ecology of Cryptococcus neoformans and epidemiology of cryptococcosis in the old world. In: Torres-Rodriguez JM, ed. Proceedings of the 10th Congress of the International Society for Human and Animal Mycology. Barcelona: JR Prous, 1988:113-9.
25. Swinne D, Kayembe K, Niyimi M. Isolation of saprophytic Cryptococcus neoformans var. neoformans in Kinshasa, Zaire. Ann Soc Belg Med Trop 1986;66:57-61.
26. Varma A, Swinne D, Staib F, Bennett JE, Kwon-Chung KJ. Diversity of DNA fingerprints in Cryptococcus neoformans. 3 Clin Microbiol 1995;33:1807-14.
27. Dromer F, Varma A, Ronin O, Mathoulin S, Dupont B. Molecular typing of Cryptococcus neoformans serotype D clinical isolates. J Clin Microbiol 1994;32:2364-71.
28. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974;80:176-81.
29. Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972;53:315-22.
30. Stevens DA. The interface between mycology and endocrinology. J Med Vet Mycol 1989;27:133-40.